8-K Ultragenyx Pharmaceutical Inc. 2026-09-02: filed_by
| Value | {"cik": "0001515673", "company": "Ultragenyx Pharmaceutical Inc.", "accession": "0001193125-26-380165", "entity_ref": "e0ead587-78d8-4a93-8c7f-70264640ad1b", "period_of_report": "2026-09-02"} |
|---|---|
| Period | (as of 2026-09-02) |
| Status | current |
| Entity | 8-K Ultragenyx Pharmaceutical Inc. 2026-09-02 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference:
Retrieved: 2026-09-02T22:12:17.277354+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/4b781ace-4eed-46fb-b75e-c870294159b7
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference:
https://www.sec.gov/Archives/edgar/data/1515673/000119312526380165/0001193125-26-380165-index.htmRetrieved: 2026-09-02T22:12:17.277354+02:00
Raw response sha256:
9c7d5f4b278532f5fd321fed3119f1cf…Cite as: FACTANKER, https://factanker.com/fact/4b781ace-4eed-46fb-b75e-c870294159b7
History
- no predecessors — first report